Sanxin Medical disclosed in its first quarter report on April 17, 2024 that the number of shareholders of the company as of March 31, 2024 was 18,300, an increase of 407 or 2.28% from the previous period (February 29, 2024).
The number of shareholders of Sanxin Medical is lower than the industry average. According to Choice data, as of March 31, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 34,500. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 29.88%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since June 30, 2023, the number of shareholders of the company has decreased, with a decrease of 5.85%. From June 30, 2023 to March 31, 2024, the stock price increased by 6.73%.
Number of shareholders and share price
Number of shareholders and share capital
As of March 31, 2024, the company's latest total share capital is 520 million shares, of which the outstanding share capital is 363 million shares. The average number of outstanding shares held by households decreased from 20,300 shares in the previous period to 19,900 shares, and the average market value of households was 144,800 yuan.
The average amount of shares held by each household
The average circulating market value of Sanxin medical households is lower than the industry average. According to Choice data, as of March 31, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 415,400 yuan. Among them, 24.90% of the company's households hold a circulating stock market value of 140,000~270,000 yuan, and Sanxin Medical is also in the range.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.